Posts tagged "lymphatic system cancer"

Lymphatic Cancer Treatment

Lymphatic cancers (also known as lymphomas) are cancers of the body’s immune system. Lymphomas can be divided into two categories: Hodgkin’s and non-Hodgkin’s , which have slightly different characteristics and cancer treatment plans.

Surgery

Radiation

Chemotherapy

Immunotherapy

Stem Cell Transplants

treatment for most patients with early stage Hodgkin’s disease is high-energy radiation of the lymph nodes. Research has shown that radiation therapy to large areas at high doses (3,500 to 4,500 rads) is more effective in preventing relapse than radiation of the diseased nodes alone.

Combination chemotherapy also is effective in the treatment of early stage Hodgkin’s disease. In addition, chemotherapy is the treatment of choice for advanced (stages III and IV) Hodgkin’s disease and for patients who have relapsed after radiotherapy. Drugs and radiation are sometimes given together, mainly in treating patients with tumors in the chest or abdomen.

Lymphatic Cancer Natural Treatment

Lymphatic cancer or lymphoma is cancer of the lymph nodes or lymph glands. The most common treatments for lymph node cancer are chemotherapy and radiation. However, some people have opted for natural treatments in hopes to cure the disease.

Fruit Juices

To help in the lymphatic cancer treatment, fruit juices and water will help by detoxifying the body according to practitioners of traditional Chinese medicine. While detoxifying your body it is advised not to consume any coffee or alcohol.

Vegetables

Traditional Chinese medical professionals believe there are many vegetables that can assist in detoxifying the body such as carrots, beets and mushrooms. By eating a combination of vegetables you are not only detoxifying your body, you are also healing your body of other possible ailments.

Echinacea

Echinacea may help in boosting the immune system and has been prescribed by professionals for several decades. Whether deciding to use all natural treatments or using medical treatments, echinacea will help in keeping the immune system working to prevent contracting other diseases and viruses.

Pau d’Arco

Pau d’arco will aide in preventing and coping with any pain that you may feel with lymphatic cancer. Pau d’arco is taken orally three to five times a day.

Red Clover

Red clover is taken orally. Red clover works as a detoxifier by ridding the body of unnecessary toxins in the body. Many physicians prescribe red clover when a patient is undergoing chemotherapy treatments, per “Herbal Remedies.”

Baths

Steam baths and cold baths help release tense muscles. The use of baths both steam and cold also help in detoxifying the body. Some choose to use salts in their baths to promote invigorating skin.

By Lisa Choat

Immunologic Approaches to the Classification and Management of Lymphomas and Leukemias (Cancer Treatment and Research)
publisher: Springer, published: 1988-05-31
ASIN: 0898383552
EAN: 9780898383553
sales rank: 5902498
price: $175.00 (new), $0.01 (used)

Selective Sentinel Lymphadenectomy for Human Solid Cancer (Cancer Treatment and Research)
publisher: Springer, published: 2005-03-21
ASIN: 0387236031
EAN: 9780387236032
sales rank: 4019283
price: $0.94 (new), $0.95 (used)

In human solid cancer, the lymph node (LN) status is the most important prognostic indicator for the clinical outcome of patients. Recent developments in the sentinel lymph node (SLN) concept and technology have resulted in the application of this revolutionary approach to define the first draining or SLN to which the cancer may have metastasized.

The underlying thesis in solid cancer biology is that metastasis generally starts in an orderly progression, spreading through the lymphatic channels to the SLN in the nearest LN basin. Thus, the logical approach is to harvest that specific SLN for thorough analysis. Because a tumorfree SLN is usually associated with a negative residual LN basin, a negative SLN is an excellent indication that micrometastasis has not occurred in the regional LNs.

When the SLN is involved, it is unknown whether or not metastasis is limited only to the SLN or if the disease has spread to the remainder of the nodal basin. For this reason, if a SLN is positive, a complete lymph node dissection is recommended. Therefore, selective sentinel lymphadenectomy (SSL) should be considered as a staging procedure so that patients with negative SLNs (about 80%) may be spared an extensive LN dissection. Malignant melanoma has been proven to be the most ideal tumor model to study the role of SLN.

Subsequently, SSL has been applied to breast cancer, colon cancer and other types of solid cancer. The multidisciplinary approach encompassing the surgeon, nuclear medicine physician, and pathologist is the key to such a successful procedure. Such a team can be formed readily with appropriate training. Beyond the technical aspects of harvesting the SLN, the implication of micrometastasis remains to be defined. Because the follow-up of melanoma and breast cancer patients after SSL is crucial, ongoing clinical trials are in progress to determine the biological and clinical significance of SLNs.

Although the concept of SLN is viable in other types of cancer, such as gynecological and gastrointestinal, the technical aspects of the procedure need to be perfected and verified. The most exciting possibility of SSL is that it will lead to early diagnosis of micrometastasis in regional LNs. Early diagnosis makes it useful as a clinical staging procedure, and opens up new opportunities to study micrometastasis and its evolution within the SLNs.

Examining the multifaceted aspects of micrometastasis, such as differentiation of different clones with respect to the primary tumor, acquisition of adhesion molecules, and host interaction with the microscopic tumor, will shed new light on the biology of early metastasis. New molecular and genetic tools may be used to dissect the mechanisms of lymphatic and hemo togenous routes of metastasis.

If such mechanisms can be understood, new therapeutic advances may be developed to prevent the process of micrometastasis. Rather than targeting larger tumor burdens such as Stage IV disease, targeted adjuvant clinical trials can be developed for high risk patients following definit ive surgical resection. SSL is a standard staging procedure for patients with melanoma and is rapidly evolving into a standard procedure for breast cancer as well.

Recommended Reading

Be the first to comment - What do you think?
Posted by admin - 26/12/2011 at 5:23 pm

Categories: Lymphatic Cancer Treatment   Tags: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

You might also likeclose
This site is protected by WP-CopyRightPro